Clinical trials during COVID-19

Head Neck. 2020 Jul;42(7):1516-1518. doi: 10.1002/hed.26223. Epub 2020 May 2.


As this ever-evolving pandemic lays itself, more of its impact is being understood. Until recently, most guidelines were reported to aid in managing and treating suspected or confirmed cases. Research institutions around the world are responding with a sense of confusion. Some are continuing routinely, especially those who are overseeing clinical trials that could offer life-saving therapies, particularly against the novel coronavirus. Since research must continue even in the face of a shutdown, we aim to collate the currently available recommendations from various organizations and provide guidance to head and neck researchers across the world during these trying times.

Keywords: COVID-19; clinical research; coronavirus; head neck; trials.

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Clinical Trials as Topic / organization & administration*
  • Coronavirus Infections / epidemiology*
  • Data Management
  • Ethics Committees, Research
  • Humans
  • Informed Consent
  • Occupational Health
  • Pandemics
  • Patient Safety
  • Pneumonia, Viral / epidemiology*
  • Quarantine
  • Risk Assessment
  • SARS-CoV-2
  • Self Administration
  • Telecommunications